Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-01-01 @ 2:14 PM
Study NCT ID:
NCT01124604
Status:
COMPLETED
Last Update Posted:
2013-05-14
First Post:
2010-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain Participants
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR016999
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None